Miami, FL, United States of America

Jesse Pelletier

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jesse Pelletier: Innovator in Ophthalmic and Dermatological Treatments

Introduction

Jesse Pelletier is a notable inventor based in Miami, FL (US). He has made significant contributions to the fields of ophthalmology and dermatology through his innovative patents. With a total of 3 patents, Pelletier's work focuses on developing effective treatments for various infections.

Latest Patents

Pelletier's latest patents include groundbreaking formulations aimed at treating infections. One of his notable inventions is an ophthalmic composition that provides stable topical formulations useful in treating viral infections, demodex infections, and bacterial infections of the eye. This invention outlines methods for using these compositions effectively. Another significant patent is for an iodophor composition, which offers stable topical formulations for treating viral wart infections, demodex infections, and bacterial infections of the skin and genitalia. This patent also details methods for applying these compositions in treatment.

Career Highlights

Jesse Pelletier is currently associated with Veloce Biopharma, LLC, where he continues to innovate in the biopharmaceutical sector. His work is characterized by a commitment to developing effective therapeutic solutions that address pressing medical needs.

Collaborations

Pelletier collaborates with talented professionals in his field, including Kara Capriotti and Kevin Stewart. Their combined expertise contributes to the advancement of innovative treatments in the biopharmaceutical industry.

Conclusion

Jesse Pelletier's contributions to ophthalmic and dermatological treatments through his patents reflect his dedication to improving patient care. His innovative work continues to pave the way for new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…